How Much Did PlateletBio Raise?
Funding & Key Investors

PlateletBio has secured $75.5M in total capital, with its most recent funding round bringing in $75.5M in a major strategic investment. This significant backing underscores the company's progress in the competitive biotechnology sector.

What is PlateletBio?

PlateletBio
Business ServicesResearch & Development

Founded in 2014 and headquartered in Chestnut Hill, MA, PlateletBio operates as a biotechnology company and cell therapy platform provider. The company is focused on developing innovative therapeutic solutions within the life sciences industry. Its strategic positioning in cell therapy suggests a focus on regenerative medicine and advanced treatment modalities.

How much funding has PlateletBio raised?

PlateletBio has raised a total of $75.5M across 1 funding round:

2021

Series B

$75.5M

Series B (2021): $75.5M with participation from K2 HealthVentures, SymBiosis, Oxford Finance, Ziff Capital Partners, and Qiming Venture Partners

Key Investors in PlateletBio

K2 HealthVentures

K2 HealthVentures is an alternative investment firm focused on providing flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. Their investment team comprises experienced professionals with deep domain knowledge across various healthcare sectors.

Oxford Finance

Oxford Finance is a specialty finance firm that offers flexible financial solutions to healthcare and life sciences companies worldwide. Founded in 2002, they provide tailored financing to support growth and innovation in the sector.

Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm that focuses on investing in innovative companies across various sectors, including technology and healthcare. They aim to support entrepreneurs by providing industry resources and strategic guidance.

What's next for PlateletBio?

The recent major enterprise-level funding indicates PlateletBio is poised for significant scaling and further development of its cell therapy platform. This capital infusion is likely to accelerate research and development, clinical trials, and potential commercialization efforts. The company's trajectory suggests a move towards expanding its market presence and solidifying its position as a key player in the biotechnology landscape.

See full PlateletBio company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesProject Management
Business ServicesResearch & DevelopmentConsumer ServicesRepair Services
Business ServicesSecurity Information and Event Management (SIEM)Consumer ServicesLandscape Services
Advertising NetworksBusiness Services

Frequently Asked Questions Regarding PlateletBio Financial Insights

What are the most recent funding rounds that PlateletBio has completed, and what were the funding rounds?
PlateletBio has recently completed 1 funding rounds: Series B on Nov 4, 2021.
What is the total amount of funding PlateletBio has raised to date?
PlateletBio has raised a total of $75.5M in funding to date.
How many funding rounds has PlateletBio completed?
PlateletBio has completed 1 funding rounds.
How much funding did PlateletBio raise in its most recent funding round?
PlateletBio raised $75.5M in its most recent funding round.
Who are the lead investors in PlateletBio's latest funding round?
The lead investor in PlateletBio's latest funding round was K2 HealthVentures. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in PlateletBio's history?
The largest funding round in PlateletBio's history was $75.5M.
See more information about PlateletBio